Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$17,500.00

The Isolation and Characterization of Pancreatic Cancer Stem Cells, and Therapeutic Targeting with TRAIL

FY 2010-11

Summary
Pancreatic cancer is the fourth most common cause of cancer-related death in North America. Diagnosis is almost certainly a death sentence as there are no effective therapies against this terrible disease. A newly emerging therapy, termed TRAIL, is showing promise at killing cancerous cells by triggering these cells to self-destruct, without harming normal cells. No study, however, has effectively looked at the response of pancreatic cancer stem cells to TRAIL. It has been suggested that these cancer stem cells may be the culprits behind an incomplete response of pancreatic cancer to TRAIL. If we can better understand the signaling pathways in these cancer stem cells, we might be better be able to target them with TRAIL, leading to a potential breakthrough in treating pancreatic cancer.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
227202
Name
Cader Sonia R
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards B
Projecttitle
The Isolation and Characterization of Pancreatic Cancer Stem Cells, and Therapeutic Targeting with TRAIL
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Apoptosis; Cancer Stem Cells; Pancreatic Cancer; Trail Ligand
Abstract
Pancreatic cancer is the fourth most common cause of cancer-related death in North America. Diagnosis is almost certainly a death sentence as there are no effective therapies against this terrible disease. A newly emerging therapy, termed TRAIL, is showing promise at killing cancerous cells by triggering these cells to self-destruct, without harming normal cells. No study, however, has effectively looked at the response of pancreatic cancer stem cells to TRAIL. It has been suggested that these cancer stem cells may be the culprits behind an incomplete response of pancreatic cancer to TRAIL. If we can better understand the signaling pathways in these cancer stem cells, we might be better be able to target them with TRAIL, leading to a potential breakthrough in treating pancreatic cancer.
Competitiondate
201102
Approvedterm2
1 yr 0 mth
Pinamesdelim
Cader, Sonia R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~